Why the study?
Cardiovascular disease is the leading cause of maternal mortality, but little data exist regarding the use of novel treatments and catheter-based interventions in the pregnant population.
This review summarizes the management of cardiovascular diseases during pregnancy, with a specific focus on the role of percutaneous and catheter-based interventions.
Answers are grounded in this paper and cite their sources.
May guide interventional decisions in pregnant patients with CVD; leaves open need for prospective safety and efficacy data.
Cardiovascular disease is the leading cause of maternal mortality worldwide and has been increasing in prevalence over the last several decades. Pregnancy is associated with significant hemodynamic changes that can overwhelm the maternal cardiovascular reserve, and may exacerbate previously asymptomatic cardiovascular disease. Complications associated with these may cause substantial harm to both the mother and the fetus, and the management of these conditions is often challenging. Numerous novel treatments and interventions have demonstrated the safety and efficacy of managing these conditions outside of pregnancy. However, there are little data regarding their use in the pregnant population. In this review, we describe the common cardiovascular diseases encountered during pregnancy and discuss their management strategies, with a particular focus on the role of percutaneous, catheter-based therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: